back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-03-29 14:02 Tx date 2024-03-27 |
$RX
BioSyent Inc. |
Moothan, Ramesh
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+3,195 vol |
17,502 | |
| Filed 2024-03-29 14:01 Tx date 2024-03-19 |
$RX
BioSyent Inc. |
Moothan, Ramesh
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$14,637
+1,722 vol $8.50 each |
14,307 | |
| Filed 2024-03-29 14:00 Tx date 2024-03-19 |
$RX
BioSyent Inc. |
Moothan, Ramesh
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-3,444 vol |
12,585 | |
| Filed 2024-03-19 10:07 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Moothan, Ramesh
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,673
+217 vol $7.71 each |
16,029 | |
| Filed 2024-03-19 10:06 Tx date 2023-12-31 |
$RX
BioSyent Inc. |
Moothan, Ramesh
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,602
+981 vol $7.75 each |
15,812 | |
| Filed 2023-04-03 10:40 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-2,997 vol |
14,831 | |
| Filed 2023-03-31 17:27 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$22,057
+2,941 vol $7.50 each |
17,828 | |
| Filed 2023-03-31 17:26 Tx date 2023-03-31 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-5,882 vol |
14,887 | |
| Filed 2023-03-13 15:29 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$480.76
+68 vol $7.07 each |
20,769 | |
| Filed 2023-03-13 15:27 Tx date 2022-12-31 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,285
+777 vol $8.09 each |
20,701 | |
| Filed 2022-04-01 11:16 Tx date 2022-03-31 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$25,997
+2,860 vol $9.09 each |
19,924 | |
| Filed 2022-04-01 09:00 Tx date 2022-03-31 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-9,050
-1,000 vol $9.05 each |
17,064 | |
| Filed 2022-03-31 13:16 Tx date 2022-03-29 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-9,050
-1,000 vol $9.05 each |
18,064 | |
| Filed 2022-03-25 16:41 Tx date 2022-03-22 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-4,475
-500 vol $8.95 each |
19,564 | |
| Filed 2022-03-25 16:39 Tx date 2022-03-24 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-4,550
-500 vol $9.10 each |
19,064 | |
| Filed 2022-03-14 11:40 Tx date 2021-12-13 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,317
+560 vol $7.71 each |
20,064 | |
| Filed 2021-03-19 16:44 Tx date 2021-03-19 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$24,360
+3,337 vol $7.30 each |
19,504 | |
| Filed 2021-03-10 16:13 Tx date 2020-12-31 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,980
+393 vol $5.04 each |
16,167 | |
| Filed 2020-04-02 12:30 Tx date 2020-03-31 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$20,999
+5,817 vol $3.61 each |
15,774 | |
| Filed 2020-03-02 08:42 Tx date 2019-12-31 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,746
+784 vol $7.33 each |
9,957 | |
| Filed 2019-03-22 Tx date 2019-03-19 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$18,807
+2,288 vol $8.22 each |
9,173 | |
| Filed 2019-03-11 Tx date 2018-12-31 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,602
+586 vol $9.56 each |
6,885 | |
| Filed 2018-03-26 Tx date 2017-12-31 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,001
+302 vol $9.94 each |
6,299 | |
| Filed 2018-01-11 Tx date 2018-01-08 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$17,443
+1,817 vol $9.60 each |
5,702 | |
| Filed 2017-07-04 Tx date 2017-07-04 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$47,995
+5,997 vol $8.00 each |
5,997 | |
| Filed 2017-07-04 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-03-15 Tx date 2017-03-15 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$14,655
+1,994 vol $7.35 each |
3,885 | |
| Filed 2016-02-25 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$7,923
+1,278 vol $6.20 each |
1,891 | |
| Filed 2016-02-25 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$7,316
+1,180 vol $6.20 each |
||
| Filed 2016-02-24 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
50 - Grant of options
|
$7,316
+1,180 vol $6.20 each |
1,793 | |
| Filed 2016-02-24 Tx date 2016-02-12 |
$RX
BioSyent Inc. |
MOOTHAN, RAMESH
4 - Director of Issuer
Direct Ownership
|
Common Shares - Options
00 - Opening Balance-Initial SEDI Report
|
613 |